North Carolina Gov. Signs Bill Legalizing Pharmaceuticals Containing THC if FDA Approves

6/16/2022

by

North Carolina Gov. Roy Cooper (D) on Tuesday signed a measure removing federal Food and Drug Administration (FDA) approved pharmaceutical medications containing THC from the state’s list of Schedule VI drugs, WGHP reports. The measure does not include medical cannabis – which was approved by the state Senate earlier this month but will not be heard in the House – the lower chamber’s leader, Rep. Tim Moore (R), said.  

The law signed by Cooper will automatically legalize any drug containing THC so long as it is approved by the FDA, the Drug Enforcement Administration makes the change to the federal controlled substances schedules, and the North Carolina Commission for Mental Health, Developmental Disabilities and Substance Abuse does not object to excluding the drug from the state’s Schedule VI.

Cooper does support broad medical cannabis legalization in the state along with most of his Democratic cohorts in the Legislature; however, both chambers are controlled by Republicans. In the Senate, two Democrats voted against the reforms – which passed 35-10 – along with eight Republicans. 

An April poll conducted by SurveyUSA on behalf of WRAL found that 72% of North Carolina voters support medical cannabis legalization, with 18% opposed. The poll also found a majority (57%) of voters back adult-use legalization. 

However, House Speaker Tim Moore said the chamber would not take up the legislation this session, likely killing the bill this year. He also declined to say whether the House would hear the bill next session.  

“I want to see where our folks are on it. I really do,” he said in an interview with WRAL. “That one has just kind of been thrown down, and I don’t see an appetite to take that up in the shorter session. As far as the long session, I won’t say one way or the other.” 

Cooper is still considering a measure to allow the state’s hemp farmers to produce CBD products. That bill was passed on June 2. 

End

Klean Scissors Completes Phase II Trials for ‘Deresinator’ Scissor-Cleaning Product

6/15/2022

by

CALIFORNIA (6/15/2022) — Klean Scissors Inc is pleased to announce the successful completion of its Phase II trials for the corporation’s flagship product, the revolutionary Deresinator.

The Phase II trials involved over one hundred hours of successful scissor cleaning in several processing facilities in Northern California. After Phase I trials, the company made slight modifications to the brush assembly and machine aperture so that the Deresinator is now compatible with all brands of trim scissors, including curved blades.

The Deresinator is the world’s first automatic cannabis trim scissor cleaning machine. It eliminates the current messy and time-consuming process of soaking the scissors in open containers of solvent for five to ten minutes and then wiping them off. It cleans resin-coated scissor blades in seconds.

The Deresinator will save growers and processers both time and money as well as offer a safe, enclosed space for potentially hazardous solvents in the workplace.

“We now have three working prototypes and patents in both the USA and Canada on a groundbreaking tool that will save an enormous amount of time when processing cannabis, an industry that is only going to grow,” said Dave Timoney, President and CEO. “We are seeking capital to begin manufacturing this break-through technology. We will also consider selling the patents and invention for the right price.”

For more information (and video): https://cleantrimming.com/

Contact
Dave Timoney (530) 277-0411
Davet19@gmail.com

 

End

Cannabis Farmers Unable to Access USDA Disaster Aid

6/15/2022

by

State-approved cannabis farmers will be unable to access federal U.S. Department of Agriculture (USDA) Emergency Relief Program funds due to cannabis’ Schedule I status under the Controlled Substances Act, Leafly reports. In an email to Leafly, a USDA spokesperson did indicate that hemp farmers would be eligible to receive aid from the program.  

“Marijuana is a controlled substance, and therefore is not eligible for federal farm programs.” — a USDA spokesperson to Leafly 

The program, announced by the USDA last month, includes $6 billion “for commodity and specialty crop producers impacted by natural disaster events in 2020 and 2021.” Cannabis farms were severely impacted by wildfires in the West during that period but will not be eligible for relief. THC-rich cannabis farmers are also prohibited from receiving aid from the federal Noninsured Crop Disaster Assistance Program, which helps farmers whose uninsured crops are damaged or lost due to natural disasters. Hemp farmers, however, are eligible for relief under the program.

According to the Center for Insurance Policy and Research, private insurers are also discouraged from assisting cannabis businesses due to “conflicting state and federal laws” and “rapidly evolving regulations,” Leafly says. The organization said that cannabis growers face similar general liabilities and risks as other farmers, such as “workplace accidents, damage to property and crop failure” but are “especially prone to fires from both wild and internal sources,” the report says.  

Aid programs in other legal states also bar cannabis companies from accessing agricultural funds. But despite lacking federal recognition, Leafly notes that cannabis is still the fifth most valuable crop in the U.S.

End

Russian Court Extends Detention of Brittney Griner

6/15/2022

by

A Russian court has extended the detention of WNBA star Brittney Griner until at least July 2, according to a report by Russian state-run news agency TASS outlined by CNN. Griner has been detained since March by Russia which accuses her of drug smuggling after allegedly finding vape cartridges containing cannabis in her luggage at customs.

Griner is considered “wrongfully detained” by U.S. officials.

In the U.S., Griner plays for the Phoenix Mercury but has played in Russia for the last seven years during the winter offseason, earning $1 million per season, which is more than four times her WNBA salary.

In Russia, Griner faces up to 10 years in prison for the drug smuggling charge. Her detention has been extended three times since her arrest

State Department spokesperson Ned Price on Tuesday said the agency’s “position for some time on this has been very clear: Brittney Griner should not be detained.” He added that the U.S. had lost consular access to Griner last month.

“She should not be detained for a single day longer.” — Price, in a statement, via CNN

Russia and U.S. relations have been strained by the former’s invasion of Ukraine and many fear that Griner will be used as a political pawn. Her case is being handled by the office of the US Special Presidential Envoy for Hostage Affairs which leads diplomatic efforts to release Americans wrongfully detained abroad. The office helped free U.S. citizen Trevor Reed in April as part of a prisoner swap with Russia.

In a statement on Twitter, Griner’s agent, Lindsay Kagawa Colas, said the “extension is just further reinforcement” that Griner “is being used as a political pawn.”

“Her detention is inhumane and unacceptable,” Kagawa Colas wrote. “She has not had a single phone call in her 117 days of wrongful detention.”

Following Griner’s arrest, the Russian Federal Customs Service issued a statement indicating that it had opened a criminal investigation into the large-scale transportation of drugs but did not name Griner.

End

Malta Company Sends Country’s First Medical Cannabis Export to Germany

6/15/2022

by

Materia Malta has shipped medical cannabis products to Germany, the first such batch shipped outside of the country, Worldakkam reports. Materia is a leading medical cannabis distributor in Europe; Materia GmbH, a subsidiary of the company, facilitated the shipment and is already selling the cannabis to German pharmacies, according to the report.

“We are proud to be a company that establishes a new frontier for the Maltese and European cannabis industry,” said Nick Paterasu, managing director of Materia in Europe.

Malta passed medical cannabis legalization in 2018 and many Maltese companies have entered the space since.

With more licenses expected in the coming months, more companies will begin exporting medical cannabis from Malta. Licenses to sell outside of Europe are only granted to companies following a rigorous process, Worldakkam reports.

Additionally, Malta Enterprises — the country’s economic development agency which provides financial packages to help medical cannabis companies build their business, purchase equipment, transfer machinery, human resources, research and development, and more — is set to launch the research and development of cannabinoid-based therapeutics and industrial processes for cannabis extraction and cultivation under the highly regulated system.

“We have been working tirelessly to achieve this result,” said Malta Enterprise CEO Kurt Farrugia. “At that moment, we will be pushed to other frontiers in the medical cannabis field.”

Malta legalized adult-use cannabis last year, becoming the first European Union country to do so. The law allows citizens aged 18 or older to possess up to seven grams of cannabis, grow four plants at home, and keep up to 50 grams at home from their harvest.

End

New Mexico Cannabis Firm Files Lawsuit Asking Health Insurers to Cover Medical Cannabis for Behavioral Health Conditions

6/15/2022

by

New Mexico’s largest licensed cannabis producer has filed a lawsuit seeking to force health insurers to cover the cost of medical cannabis for patients enrolled in the state program for behavioral health conditions, the Santa Fe New Mexican reports. The lawsuit claims that a law passed last year, which prohibits insurers from requiring patients to share the cost of medications for mental or behavioral health, should apply to patients using cannabis for their conditions.

The class-action lawsuit on behalf of six named patients by Ultra Health also seeks damages since the patients have been forced to pay the total cost for their own medical cannabis used to treat their mental health and behavioral conditions.

The complaint, which was filed last week in state District Court in Bernalillo County, also seeks “disgorgement of the millions of dollars in excess profits and revenues retained” by the insurance companies via an award of an unspecified amount of punitive damages to be determined by a jury.

One of the named plaintiffs is state Sen. Jacob Candelaria (D) who uses cannabis to treat symptoms of post-traumatic stress disorder.

Ultra Health President Duke Rodriguez estimated that about 55% of the state’s medical cannabis patients – about 74,000 people – are enrolled in the program, at least partly, for PTSD-related symptoms.

“The idea of health insurance plans paying for medical cannabis may seem like an impossible dream, but all the foundational elements have already fallen into place. Revolutionizing behavioral healthcare in New Mexico will take only a few small steps, rather than a giant leap.” — Rodriguez in a statement, via the New Mexican

The insurance companies named as defendants include Blue Cross and Blue Shield of New Mexico; Cigna Health and Life Insurance Company; True Health New Mexico; Molina Healthcare of New Mexico; Presbyterian Health Plan; Presbyterian Insurance Company; and Western Sky Community Care, the report says.  

Ultra Health and Rodriguez have previously sued the state over plant counts, purchase limits, and the number of dispensaries allowed by licensees. In February, in a lawsuit brought by Ultra Health, the state Supreme Court ruled that medical cannabis purchases in the state are not subject to its gross receipts tax.  

Medical cannabis producers in the state had requested tax refunds in 2014 and in 2018 but the state Taxation and Revenue Department had denied those claims. In 2020, New Mexico Court of Appeals Judge M. Monica Zamora ruled that medical cannabis should be treated like other prescriptions, which are not taxed. Ultra Health had not been charging patients taxes, opting instead to absorb such taxes. The company said that it would receive a $7.4 million refund plus interest following the Supreme Court ruling.

End

These Are the Claims CBD Companies Can Legally Make About Their Products

6/14/2022

by

The CBD market is one of the fastest-growing segments in the health and wellness space. CBD sales in the U.S. reached $4.6 billion in 2020 and are expected to hit $20 billion by 2024.

The purported therapeutic effects of CBD have created a buzz and prompted many people to explore how the cannabinoid can improve health and well-being. As such, there is an increasing demand for CBD supplements, and companies are seizing the opportunity to cash in on the trend.

However, the CBD industry is not without its challenges, especially surrounding the evolving legal landscape. The 2018 Farm Bill made hemp federally legal, but marijuana is not, and CBD can be derived from both cannabis plants – creating a great deal of confusion.

Another issue is that CBD is not FDA-approved, so it cannot be marketed as a dietary supplement. Below, we explore the CBD claims companies can and cannot make about their products.

Do Not Make Medical Claims About Your CBD Product

The 2018 Farm Bill federally legalized industrial hemp and, by extension, its derivatives like CBD. As a result, CBD was removed from the federal Controlled Substances Act and is no longer overseen by the Drug Enforcement Agency (DEA). Instead, the hemp industry and CBD governance is now controlled by the FDA.

The FDA is currently still investigating the compound’s safety for human use and devising regulations, leaving the CBD industry in a legal gray area.

Any product intended for medicinal use or used to affect the function or structure of the body must be reviewed and approved by the FDA. Since CBD is not yet FDA-approved, any health claims may be considered misleading.

Over the last couple of years, the FDA has made it clear that it will not tolerate companies making unproven health claims about CBD products. The organization has sent warning letters to various companies that are making “egregious and unfounded” claims about CBD’s health benefits.

Avoid Stating or Implying Disease Claims

A common theme among the companies that received warning letters from the FDA is that CBD products were marketed as a treatment or cure for serious diseases, such as Alzheimer’s and multiple sclerosis.

You cannot explicitly state or infer that a CBD product can cure, treat, or prevent any illness or mitigate the symptoms of an illness. In general, steer clear of mentioning specific diseases like cancer or fibromyalgia.

Avoid Making Structure-Function Health Claims

The FDA describes structure-function claims as those relating to well-being and nutrient deficiencies. In most cases, these claims describe how an ingredient (like CBD) affects the normal function and structure of the body.

Such claims aren’t pre-approved for supplements, but companies can notify the FDA of the claim within 30 days of marketing the product. However, since CBD isn’t FDA-approved, it’s best to avoid these claims altogether. Examples include “fights symptoms like flu and cold,” “improves brain health,” and “eliminates wrinkles.”

Don’t Recommend CBD as a Substitution for Another Drug

You cannot legally advise customers about using CBD to treat a specific medical condition, disease, or ailment. Only doctors can do this. Similarly, you cannot market your CBD products to substitute other pharmaceutical drugs. For instance, you cannot market CBD as an alternative to PTSD or epilepsy medication.

Claims You Can Legally Make About CBD Products

Any claims about the purported health effects of CBD products must be backed up by reliable scientific evidence. It’s often best to avoid making health claims altogether to ensure you’re playing by the FDA’s rules. Reputable companies like PureKana are great examples of how to market CBD products.

Here are some guidelines relating to the claims companies can make about CBD products.

Claims Pertaining to Temporary States or Emotions

As long as there is no implication that CBD can treat or prevent disease, claims related to temporary emotions are usually permissible. For instance, you can say things like “eases stress,” supports mental clarity,” and “targets occasional pain.”

The idea is to not overpromise or mislead customers. It must be clear that CBD is not intended to treat a specific medical condition. Qualifiers like “mild” or “occasional” help differentiate between temporary conditions and symptoms of diseases.

Claims Pertaining to CBD’s Effects on General Health

Although CBD cannot be marketed for specific health conditions, companies can make claims about how its therapeutic effects may benefit general health and wellness. Use words like “wellness,” “supports,” and “maintains.” For instance, you could say that CBD enhances wellness, supports healthy sleep cycles, or helps maintain a sense of wellbeing.

Refer to General Body Parts Including Systems

It’s also okay to make claims relating to CBD’s effects on general body parts and systems. For instance, you can claim that CBD supports a healthy immune system or that it can be used for joint and muscle aches. Another example is instead of saying that CBD can treat chronic fatigue, you could say that it improves daytime mental alertness.

However, if you make any structure-function claims, you must use an FDA disclaimer asserting that “these statements have not been evaluated by the Food and Drug Administration.”

Utilize Cosmetic Claims

It is perfectly fine to make claims about how CBD can improve one’s outer appearance without affecting the structure or function of the body. However, companies must still be careful not to mislead customers and ensure products are safe for use.

Examples of cosmetic claims include “balances uneven skin tone,” “helps tighten and firms,” and “smooths and hydrates.”

Final Thoughts: Claims Companies Can Make About CBD Products

CBD retailers who make unsubstantiated health claims about products could face legal action. In general, companies should avoid making health claims for specific diseases, steering clear of words like “cure,” “treat,” and “prevent.” Any claims relating to the health effects of CBD products should be backed up by sound science.

In general, be careful not to make any definitive claims about CBD’s health benefits. There is a fine line between making health claims and simply relaying how CBD may support health and wellness. Until CBD is FDA-approved, companies need to be very careful when marketing CBD products.

End

Judy Yee: Expanding Cannabis Access With Infused Beverages

6/14/2022

by

Beverages are one of the fastest-growing categories in adult-use states: consumers who are looking for an alternative to drinking alcohol at social gatherings are turning to low-dose products they can sip while engaging with their friends. But perfecting a cannabis beverage product takes an understanding of the market, the right infusion method, and a delicate hand when flavoring.

We recently caught up with Judy Yee, CEO and co-founder of K-Zen, to learn about the process of starting and scaling a cannabis beverage business in California. In this interview, we cover Judy’s background in healthy food and beverage, the process of catering product education and packaging to your target market, the thoughtful cannabis drinks offered by K-Zen, and more!

Continue scrolling to find the full interview.

Ganjapreneur: What is the founding mission and inspiration behind K-Zen?

Judy Yee: The name “K-Zen” draws on the Japanese term, “Kaizen,” which means continuous improvement in all aspects of life. This ethos is what drives us to bring the highest quality, best tasting and most consistent products to market for different types of consumers.

We are committed to normalizing cannabis and inspiring new ways for consumers to enjoy its benefits. Our founding mission is to create a portfolio of cannabis beverage brands that people love and trust by delivering consistent formulas, great-tasting flavors and rapid, predictable effects.

How did you meet co-founder Soon Yu and when did you decide to start K-Zen together?

I first met Soon Yu in 1998 where we were both working for Clorox. We stayed in touch throughout our careers, sharing similar interests for disruptive trends that impacted the CPG space. In 2018, Soon was returning to the Bay Area from his last venture with VF Corp (working with iconic retail brands like Vans and North Face). We got together, as we often do, to discuss emerging trends and I shared my thoughts on cannabis as that next “big thing” to happen in the food and beverage space.

I was also seeing consumers lean towards “healthier” options and alternatives (e.g., bottled water sales exceeded soda sales in 2016, and millennials were consuming less alcohol). At the same time, I was discovering cannabis as a less conventional method for my own personal health and well-being. This was the tipping point that launched K-Zen.

What should an entrepreneur look for in a co-founder relationship? Can you share any red flags that aspiring entrepreneurs should avoid when bringing someone in on a business idea?

I hope I’m not stating the obvious when I say pick someone you trust. Soon Yu was, and is, a boon to K-Zen and to me personally. When you’re starting a new business, whether it be in an industry that’s well established or one that’s budding like ours (excuse the pun), it’s so important that you have someone at the outset. Our backgrounds and skills are pretty complimentary. We’re able to work well together while also balancing each others’ strengths and weaknesses. I suppose that’s another thing I’ll say — in business, you need to know that your partner is going to tell you the truth instead of protecting your feelings. That’s something that I have found to be really valuable as a CEO.

I would say my biggest red flag in any potential partnership or in regards to any business deal would be if they don’t honor their commitments, or if their core values don’t match with yours. I’m a big believer in doing what you say you will and having integrity while you do it. It is, of course, normal to disagree on certain aspects of the business, but your ideas for your company’s mission and purpose should align.

What inspired you to enter the healthy food and beverages industry, and how does that inspiration drive your trajectory in the cannabis space?

I’ve always been a really active person and cognizant of how fueling your body with the right things can make a huge impact on who you are. I think I was most aware of this when I danced for the Seattle Supersonics — gosh, that was forever ago — and was in the best shape I’ve ever been in!

Later on in my career, I held senior level positions at companies like Earthbound Farm, Chiquita and Crystal Geyser, so I have firsthand experience working with brands that value whole ingredients. I really enjoyed that work, but it wasn’t until later that I felt called to explore a new industry entirely.

Because of my involvement and dedication to these other facets of healthy-living, I found that I had been neglecting another. I actually didn’t try cannabis until I was in my 40s after having my first child. Recovering from pregnancy and giving birth was a lot harder than I thought it would be, and I felt unmotivated to get back into the fitness routine that I’d loved so much — not to mention the fact that remedies I’d used in the past weren’t as effective. Cannabis not only helped me navigate my way back to a routine that is active and painless, but it also has helped me manage my time between being a busy entrepreneur and a hands-on mother. Now, I work day in and day out to make cannabis a part of other people’s wellness journeys, which feels right to me.

Why did you choose to develop cannabis drinks products for your entry into the cannabis space?

Normally when people think about cannabis consumption, they imagine smoking a joint, hitting a cartridge, or maybe eating a “pot brownie.” I have asthma, so smoking is really out of the question for me and I’m also not big on sweets, which means edibles aren’t really a go-to for me either. When I was considering starting my own cannabis business, I was thinking about a way for people to consume cannabis that is familiar, discreet and tasty. A beverage seemed like the most obvious choice!

I also think that consumers are used to trying “super ingredients” or adopting a new routine through drinks. For ex: for many, energy drinks are now a part of one’s daily routine that didn’t exist years ago. Mad Lilly Spritzers, for example, are low calorie (with less than half the calories of a typical alcoholic seltzer), are made from 100% natural ingredients, and help take the edge off after a long day… without leaving you dehydrated and hungover the next day.

How does your extensive experience in Healthy Food & Beverage CPG serve you when facing challenges and setbacks during the R&D process? (Could you describe an experience that you remember?)

I was extremely fortunate I could leverage my food and beverage background and started researching and experimenting with cannabis. It was challenging (in a good way), and eventually, I found and partnered with a team of highly skilled food scientists and cannabis experts. Together, we created great tasting cannabis beverages and that’s how K-Zen was founded.

When we launched our first iteration of S*SHOTS in the summer of 2020, there were some things we got right and some things we didn’t. Rapid prototyping, getting early consumer feedback and optimizing your product proposition from there is a common practice from what I’ve done in CPG. We were then able to relaunch the S*SHOTS brand with much greater success and market traction.

Mad Lilly spritzers recently launched in can form after being previously sold in bottles, what inspired this packaging change? What is the process of making this change to an established product?

We just introduced Mad Lilly Spritzers in 12-ounce cans at Hall of Flowers in Palm Springs last month. While we loved the unique look of Mad Lilly Spritzers in painted glass bottles, cans are much easier to stock and distribute for our partners and retailers. The new can design is sleek and convenient and maintains the delicious taste, quality and freshness customers expect from our Spritzers.

In doing so, we were also able to bring the price point down, which I’m sure our customers greatly appreciated!

Where does K-Zen source its cannabis products? Does the brand do any in-house manufacturing or outsource the extraction process?

Cannabis oil and water need to be blended evenly to deliver consistent and rapid onset. Using cannabis in an emulsified format achieves that. So, we source our cannabis emulsion from Vertosa. We currently do not manufacture anything in-house, however, we have created and implemented best in-class manufacturing practices from our prior experience in food and pharmaceutical manufacturing in all of our co packing SOP’s to ensure quality and effective products.

How and why does K-Zen prioritize education around proper dosing and avoiding overconsumption?

At K-Zen, we know that cannabis tolerance varies from consumer to consumer — it’s only fun and properly works if you take the right dose! That’s why we make it clear on every product how much THC/CBD is included per serving.

For Mad Lilly Spritzers, portion-control and dosing is made easy because of the nature of the can. One can equals one 5 MG dose of THC and one 5 MG dose of CBD, which for most consumers will provide a light and airy high, coupled with the CBD to relax and refresh after a long day, or even as a midday pick-me-up.

Our Mad Lilly Tonic comes in single-dose bottles, too, so it’s easy to know how much you’re taking right before bed. Customers are always welcome and encouraged to ask us questions. If you go to our website, you’ll see under our FAQs that we have a phone number anyone can text at any time of day, so if ever there’s concern, our team can help you handle it straight away.

We also made a concentrated effort with S*SHOTS to ensure that our consumers were making the most of our product without taking the most. When you buy in-store, you’re gifted a complimentary S*SHOTS glass which will hold 10 ml of liquid, or one “shot” of the beverage. We always encourage our new customers to try half a shot (or maybe less, depending on your tolerance level) and see how they feel before coming back for more. But that’s why the dosage is printed in big bold letters on the label. You can’t miss it!

Who is the target consumer for K-Zen products? How does the packaging and marketing signal to that target market?

When I started K-Zen I knew I wanted to create different cannabis-infused beverages for different types of consumers, whether they were a first-timer, canna-curious or a cannabis pro, which is how Mad Lilly and S*SHOTS, respectively, were born.

I’ll talk about Mad Lilly first because we just released our new line of cans and I’m really excited about them! When you look at the packaging, you’ll see that they’re colorful, bright and airy, with floral decals and our tagline, “Wildly Tasteful” right on the side. We wanted to curate an inviting feeling without being too in-your-face. Mad Lilly Spritzers are meant for someone who’s curious about trying cannabis for the first time, or is looking for a way to experience a mellow high without feeling bogged down by a sugary edible or a coughing fit (as someone who lives with asthma, I know how that can go!). We wanted this to be something you’d reach for after a long day at work or with your kids, look at it and feel like good things are coming your way. At its core, Mad Lilly is meant to spark joy, and feel like a treat that you won’t feel guilty about.

Our packaging for our Mad Lilly Tonic is a little different, since the tonic is meant specifically to be taken for a good night’s sleep. The label is a deep purple and we called it “Lemon Dream” — it’s also infused with lavender extract with the hope that our customers can put two and two together easily. It’s a low-dose tonic so we wanted the packaging to feel grounding –– no frills.

As for S*SHOTS, they were created for an entirely different demographic. We wanted to attract experienced cannabis users. For S*SHOTS, we capitalized on, well, capitalization. On an S*SHOTS bottle, the flavor name is capitalized, as is the fact that each bottle contains 100 MG of THC. Admittedly, we were a little inspired by the alcohol industry — the S*SHOTS customer is likely someone who likes to take shots, so we wanted to sell this product as something that’s a viable substitute. The names of each flavor are also meant to elicit some excitement: Berry Blast, Lemon Crush, Tropical Thunder, and Watermelon Punch all promise to deliver that THC high consumers love. Personally, I love the way this packaging turned out. It just gets you excited about what’s in store for you after an S*SHOT (or two)!

Will the brand enter new product sectors? If so, what type of products most interest you?

We will continue to play in the beverage space as we add more flavors or new segments within the category. In fact, we have a new flavor of Mad Lilly Spritzers that will be launching later this summer — so stay tuned for more details!

We’re so grateful that Judy could take the time to answer our questions. Learn more about Judy Yee and K-Zen at kzen.co.

End

Germany Begins Hearings for Cannabis Legalization Plan

6/14/2022

by

Germany has started expert hearings for its plan to legalize adult-use cannabis, the Associated Press reports. On Monday, the German Health Ministry shared it would begin holding expert hearings with the goal of crafting legislation by later this year. The hearings started on Tuesday and include over 200 representatives from the medical and legal fields and other disciplines.

Government officials and unnamed international experts are expected to join the hearings, five of which will be held throughout the coming month, according to the report.

In a statement, Drug Czar Burkhard Blienert said he has “worked for years toward us in Germany finally ending the criminalization of cannabis consumers” and that his goal is a “modern and health-oriented cannabis policy.”

Germany’s plan to legalize adult-use cannabis is part of a deal between a coalition of three socially liberal parties that make up Chancellor Olaf Scholz’s government. In their plan, the coalition says they will ensure quality control and revisit the “social effects” of adult-use cannabis after four years, the AP reports.

Niklas Kouparanis, CEO of Bloomwell Group, a Frankfurt-based medical cannabis holding company, told Ganjapreneur in an email, “The announcement that the hearings will take place is a clear signal to the market, investors, and consumers alike that the government is very serious about legalizing adult-use cannabis in Germany.

“It’s also encouraging that experts are being consulted in preparation of drafting the legislation and that key issues are being addressed, including consumer protection, supply chain, protection of minors, international experience, among other issues. I’m completely convinced that many European countries will follow Germany’s way to legalize the adult-use industry. That said, I would like to emphasize that Germany shouldn’t rush the draft of this legislation. It can only become a role model for other countries if the legal framework is 100% waterproof.” — Kouparanis, in an email

In December 2021, Malta became the first European Union member to legalize cannabis for adults.

End

Colorado Town Considering Changing Its Name to ‘Kush’

6/14/2022

by

A Colorado town is considering changing its name to “Kush,” after the type of cannabis that originated in the Hindu Kush mountain region, the Washington Post reports. The town, Moffat, has a population of about 120 people and proponents say the name change could revitalize the town’s identity and culture while opponents contend it would be disruptive. 

The proposal was brought by Mike Biggio, co-founder of Area 420 which provides land to commercial cannabis cultivators. Biggio told the Post that he is “trying to create something like what happened with Napa Valley or even Humboldt” for the area’s cannabis industry. 

“I think if we can re-brand this and have that designation, then this could be a world-renowned region for cannabis production.” — Biggio to the Post 

Town Trustee Ken Skoglund, a 40-year resident of Moffat, opposes the change, saying that, while he acknowledges the cannabis industry has led to positive changes in the town, it would create frustrations for residents, who would have to change their licenses, addresses, and other identifying documents. 

“It’s a good industry for Moffat,” he told the Post, “but that doesn’t mean it should come in and change the name of the town and disrupt a whole bunch of other people that don’t even care for marijuana.”

The town is currently named after David H. Moffat, a Colorado businessman and railroad builder.

Skoglund said the residents are open to referring to Moffat as “The Kush Capital of Colorado.” The residents met last week to discuss the name change but no decision was made.

End

Thailand Gives 100 Cannabis Plants to Citizens, Plans to Give Away 1M Plants

6/14/2022

by

Thailand’s health minister on Friday gave away 100 cannabis plant seedlings, one day after the nation legalized the cultivation and trade of cannabis, the Associated Press reports. The giveaway is part of a plan by officials to give away 1 million cannabis plants to Thai citizens. 

The first plants were distributed in the Buriram province, considered a stronghold of the Bhumjai Thai party of Health Minister Anutin Charnviraku, which draws from the support of low-income farmers in the region. During the event, Anutin said cannabis legalization would bring financial benefits to “individual growers, community farmers (and) entrepreneurs.”      

Government officials insist that the reforms only legalize medical cannabis; however, there are no plans for monitoring small-scale cultivation and sales, the report says. 

In February, Anutin gave final approval to remove cannabis from the nation’s Narcotics List but has indicated that individuals using cannabis in “nonproductive ways,” such as public consumption, could still face penalties, such as three months imprisonment and a fine up to $780. Officials have said they are not trying to create a tourism industry around cannabis.   

According to the Thai Industrial Hemp Trade Association, the market value of cannabis-related businesses is estimated at more than $1 billion and is expected to nearly double by 2024. Cafes and restaurants are permitted to sell cannabis products in Thailand as long as the products don’t exceed 0.2% THC. 

Bhumjai party officials said more than 350,000 households have already registered with the government to cultivate cannabis. 

End

North Carolina House Leader: Medical Cannabis Bill Won’t Reach Chamber Floor

6/14/2022

by

Following the Senate passage of a medical cannabis bill in North Carolina, House Speaker Tim Moore (R) has indicated the measure is unlikely to reach the chamber floor for a vote, North Carolina Public Radio reports. Without the support of House Republicans, the bill is likely dead for the year.  

Moore, who opposes the reforms, told WRAL News that he won’t consider the measure as the state’s legislative session winds down and did not say whether the chamber would hold a vote on the bill in the future.    

“I want to see where our folks are on it. I really do. That one has just kind of been thrown down, and I don’t see an appetite to take that up in the shorter session. As far as the long session, I won’t say one way or the other.” — Moore to WRAL 

An April poll conducted by SurveyUSA on behalf of WRAL found that 72% of North Carolina voters support medical cannabis legalization, with 18% opposed. The poll also found a majority (57%) of voters back adult-use legalization. 

The poll found that 64% of Republicans approve of medical cannabis legalization along with 75% of Democrats.  

In a statement to WRAL, Jordan Monaghan, a spokesman for Democratic Gov. Roy Cooper, said the governor “supports efforts to make medical marijuana available.” Lawmakers this session passed a bill to legalize medical cannabis were the Food and Drug Administration (FDA) to do so first and Cooper is still assessing that measure.  

The FDA-oriented bill requires the agency first approve cannabis as a prescription drug, then the Drug Enforcement Administration must make the proper change to federally controlled substance schedules, and finally, a North Carolina commission would have to not object to the change. 

The broad medical cannabis legalization bill had been approved by the Senate 35-10. 

End

Oregon Bans Synthetic Cannabinoid Sales on Open Market

6/13/2022

by

Starting next month, the sale of synthetic cannabinoid products at Oregon grocery stores and other retailers will be banned, The Oregonian reports. State officials say the move is due to concerns about chemicals used in the production of the products.

The new rules also specify that industrial hemp products “may not contain any artificially derived cannabis.”  

Violators of the new rules may face fines up to $10,000. 

Supermarkets and other stores that wish to sell the products must now obtain a special license and beginning in July 2023, synthetic cannabinoids will only be available in Oregon Liquor and Cannabis Commission (OLCC)-approved shops and such products will have to receive federal approval from the Food and Drug Administration.  

Steven Crowley, the hemp and processing compliance specialist with the OLCC, told The Oregonian that while the agency is testing for pesticides and residual solvents from extraction processes, the agency doesn’t “have any testing for any of the whole universe of chemical reagents” used to “synthetically turn one cannabinoid into something else, or for any of the byproducts of that reaction.”

“The supply of CBD was outstripping the demand for CBD. And so, the people who had CBD on hand were looking for other ways that they could market it. People started working on different products that they could convert the CBD into. This is where you get the delta-8 THC products.” — Crowley to The Oregonian 

The OLCC rules would also require disclosure labels for products that contain a synthetic cannabinoid.  

Oregon is the first state to ban synthetic cannabinoids on the open market. 

End

Massachusetts Municipalities Have Collected More Than $53M in ‘Impact’ Fees from Cannabis Firms

6/13/2022

by

Massachusetts municipalities have collected more than $53 million in “impact” fees from cannabis companies since the launch of adult-use sales in 2018, according to a Northeaster University study published by the Massachusetts Cannabis Business Association outlined in a Boston Globe report. The survey of 88 communities comes as lawmakers are considering a bill that would essentially force towns and cities to justify any fees on cannabis businesses that exceed those levied on other businesses.  

State Senator Sonia Chang-Díaz (D), a sponsor of the legislation, told the Globe that the report further shows how arbitrary and unequal the process has become.” 

“I look forward to the day soon when our cannabis marketplace lives up to our values and aspirations.” — Chang-Díaz to the Globe  

The state’s legalization law allows communities to impose a 3% tax on cannabis sales, plus impact fees of up to 3% of a company’s annual revenue, providing the fee is “reasonably related” to costs imposed by the facility; however, due to lax oversight, many cities and towns have charged businesses the maximum amount without citing specific impacts, the report says. Local officials argue that the fees were negotiated in good faith and have helped mitigate regulatory costs and other issues such as increased traffic.  

Of the 88 municipalities that said they had collected fees as part of their local agreements with cannabis companies, just 47 reported the amount in response to a public records request by the researchers, which suggests the $53.3 million total is less than the actual amount collected. 

Fall River collected the most in fees from cannabis operators, $5.34 million, but did not tell researchers how that money was spent. Former Fall River Mayor Jasiel Correia was sentenced in September to six years in prison for extorting cannabis companies during his time in office. 

Devon Fields, administrative services director for Brookline, said the $4.9 million it collected in fees was “justified” due to increased administrative costs, issues in the neighborhoods, and an increase in town meetings. He told the Globe it “would be a shame” if the money “were to come to a halt.”  

“We incurred a ton of neighborhood impacts,” he told the Globe, “including disorderly conduct as well as trash and litter and parking and traffic enforcement issues.” 

Only 42 municipalities provided researchers with information on how they were spending the revenue, with half indicating they put the money in their general funds, which allows it to be spent on any number of local initiatives and budget items, regardless of whether they were related to the impact of the cannabis industry. The town of Maynard spent some of its $137,000 in fees on four park benches, while the town of Wareham used the majority of the $1.7 million it collected toward new police headquarter, the researchers found.  

Jeffrey Moyer, a Northeastern public policy professor who oversaw the study, said the research “shows that while some municipalities are following the spirit of the law and striving for real transparency, most are not.” 

End

Nebraskans Strongly Favored Medical Cannabis Reforms in ‘20 and ‘21

6/13/2022

by

A University of Nebraska-Lincoln survey published last month estimates that in 2020 and 2021, 83% of Nebraskans supported medical cannabis legalization in the state, the Lincoln Journal Star reports. The survey also found that in 2020, 40% of state residents supported adult-use reforms and that support increased to 46% last year. 

The results of the Nebraska Annual Social Indicators Survey, published May 17 in the Journal of Drug Issues, match with internal polling conducted by Nebraskans for Medical Marijuana that found 80% support for medical cannabis legalization in the state.   

The survey comes as activists are collecting signatures for a medical cannabis ballot initiative, hoping to put the issue to voters during the midterm elections.  

Nebraska Gov. Pete Ricketts (R) is an opponent of medical cannabis legalization, going so far as to appear in an ad paid for by SAM Nebraska, an affiliate of anti-legalization group Smart Approaches to Marijuana (SAM), saying cannabis is “not medicine.”  

“The only difference between medical marijuana and recreational marijuana is word choice,” Ricketts said on the spot. “Doctors can’t prescribe it and pharmacists can’t provide it because it’s not medicine.” 

A petition to legalize medical marijuana in Nebraska met the number of signatures needed to be put in front of voters in the 2020 general election but was later struck from the ballot by the state Supreme Court, which determined the question violated the state’s single-subject rule for initiatives. Two petitions are currently being circulated: one requiring the Legislature to enact laws protecting doctors and patients, and another protecting private entities that supply and distribute cannabis. 

End

Distru Connect Launches to Streamline the Vendor-to-Retail Reordering Process

6/10/2022

by

Distru, a seed-to-sale ERP for cannabis operators, today announced the launch of Distru Connect, an intelligent inventory data platform that gives brands and distributors real-time visibility into inventory levels at retail and take actions that limit revenue loss, optimize production, and understand campaign performance.

The volatility of current market dynamics require brands and distributors to collaborate very closely with their retail partners to ensure survivability through these times. Never before has it been more imperative for all participants in the cannabis supply chains to make data-informed business decisions, and to do so requires real-time transparency into inventory data, helping them answer questions like:

  • Which SKU(s) are and are not selling at the rates we need them to?
  • What is the opportunity cost of not placing a particular SKU on the shelf?
  • Should production double down on a particular category?
  • What is our ideal product mix?

The newly released analytics tool enhances the vendor-retailer relationship by providing a normalized 2-way view of inventory data including amounts, velocity, days to stock out and more, all available for SKU level and time-range filtering. In addition, Distru Connect equips brands and distributors with powerful tools that enable them to forecast opportunities, shorten the order cycle, control inventory costs and production risks with inventory visibility, set inventory par level alerts, optimize their product mix and more.

Access to normalized data helps drive productive dialogue and efficiencies across the entire supply chain by ensuring all parties have access to the same, normalized data, in a safe and secure manner. With vendor managed inventory, retailers can:

  • avoid costly stock-out events of their top selling products
  • reduce payments to brands by optimizing days of inventory on hand
  • minimize the back and forth requests around inventory levels and campaign effectiveness

Though retailers have their own preferred inventory management style and tools such as POS and analytics software, Distru Connect focuses on bringing everyone on the same page with the same data. The platform is launching with top brands in California that will be announced in the coming months.

For more information regarding Distru Connect, please click here.

About Distru
Distru is a seed-to-sale ERP for cannabis operators, giving them the ability to manage their inventory, orders and customer relations from a single platform, while staying compliant with Metrc. Currently, Distru’s SaaS tool serves hundreds of licensees across several markets in the U.S, with over $1B in transactions passing through its platform annually. Distru is widely known for its user experience, best-in-class Metrc integration, and customer support. Visit Distru.com to learn more.

End

Thailand Legalizes Cannabis Cultivation and Trade

6/10/2022

by

Thailand on Thursday legalized the cultivation and trade of cannabis, the first Southeast Asian country to pass the reforms, the Washington Post reports. Thai Health Minister Anutin Charnvirakul said he hopes the move will boost the nation’s economy, particularly its agricultural sector.

In February, Anutin gave final approval to remove cannabis from the nation’s Narcotics List and last month announced a plan to give away 1 million cannabis plants to citizens. Thailand legalized medical cannabis in 2018. 

Anutin has indicated that individuals using cannabis in “nonproductive ways,” such as public consumption, could still face penalties, such as three months imprisonment and a fine up to $780, the report says. Officials are not trying to create a tourism industry around cannabis.  

“We [have always] emphasized using cannabis extractions and raw materials for medical purposes and for health. There has never once been a moment that we would think about advocating people to use cannabis in terms of recreation — or use it in a way that it could irritate others.” — Anutin to CNN  

According to the Thai Industrial Hemp Trade Association, the market value of cannabis-related businesses is estimated at more than $1 billion and is expected to nearly double by 2024. Cafes and restaurants are permitted to sell cannabis products in Thailand as long as the products don’t exceed 0.2% THC. 

Health Ministry official Paisan Dankhum told Reuters that nearly 100,000 people have signed up with the government, via the PlookGanja app, to grow cannabis. The Health Ministry said it has approved 1,181 cannabis-derived products, including cosmetics and food, and officials expect that the industry will earn as much as 15 billion baht ($435.16 million) by 2026. 

End

Sweetleaf Collective’s Patient Network to See $5 Million Product Donation by Pro Farms, Almora and Deibel Bioscience

6/10/2022

by

The non-profit will utilize 2,000 pounds of product to help low-income patients gain access to cannabis.

Santa Barbara, Ca. (May 8, 2022) — Pro Farms, Almora and Deibel Bioscience of California have teamed up to donate over $5 million worth of cannabis products to Sweetleaf Collective’s patient network. Sweetleaf Collective is a nonprofit assisting low-income patients in gaining access to medical cannabis. Affected groups include veterans, people of color, as well as HIV and cancer patients. Pro Farms and Almora are set to donate over a ton (2,000 pounds) of state-tested and approved high-quality, California sun-grown cannabis. Deibel Bioscience of California has donated its testing services to the cause. According to Sweetleaf Collective founder “Sweetleaf” Joe, this is the largest cannabis donation for compassionate use in California history.

“With the growth of the retail cannabis industry and rising costs of regular goods such as groceries and gas, access to cannabis for low-income patients is harder than ever. We need corporate donations in addition to individual donations if we’re going to meet growing demand,” said “Sweetleaf’ Joe, founder of Sweetleaf Collective. This donation will serve thousands of patients in California. There are currently over 1,000 patients on the waiting list to access medical cannabis and this donation will service those on Sweetleaf’s list and more. Sweetleaf is accepting financial donations to help organize patients through PayPal as well as cryptocurrency.

“We’re in business to grow great crops and do great things. We’ve become a renowned, family-owned, California sun-grown cannabis farming company because of this and now we’re in partnership with Almora and Sunsmoke which are fantastic, affordable and compassionate brands with a variety of excellent products,” said Wil Crummer, CEO of PRO Farms. “Meaningful, philanthropic donations are a foundational aspect of our overall company ethos and in collaboration with Sweetleaf Collective, we’re immensely proud to be donating so much high-quality cannabis to so many patients in such need.” Crummer concluded. “It just feels so right.”

Access to high-quality, cannabis is necessary for medical patients, which is why Deibel Bioscience of California is donating tens of thousands of dollars in testing services to ensure high product quality and standards are met. “Deibel Bioscience of California is a family-owned company committed to providing accurate, independent, and compliant testing; so we felt it was important to support and partner with this cause to ensure that patients receive the safest products possible,” said CT Deibel, CEO for Deibel Bioscience of California.

“The team at Almora couldn’t be more excited to be a part of this donation that is so desperately needed in our communities throughout California. We believe in radiating love through our products and our people, and we hope that love will find its way to the patients these products will serve,” said Kristen Everhart, Almora Brand Director.

ABOUT SWEETLEAF COLLECTIVE
Founded in 1996, Sweetleaf Collective is California’s oldest cannabis brand and registered nonprofit. Sweetleaf Collective helps give access to high-quality, tested cannabis products for low-income patients experiencing cancer, HIV, terminal illness and PTSD. These patients are often minorities and veterans, but with the growth of the legal cannabis market and ballooning costs, the needs of low-income patients are greater than ever. Corporate donations are necessary to meet the needs of California patients. Corporate sponsors can get involved by visiting www.SweetleafCollective.org or emailing Sweetleafjoe@gmail.com. Individual donations can be made via PayPal on the Sweetleaf website as well as with cryptocurrency.

ABOUT PRO FARMS
As one of the largest outdoor, sun-grown cultivators in the world, we’re all in on utilizing the best of organic farming principles and practices at our family-owned and operated farms. We’re extremely proud to say that with our patients and clients in mind, we’re committed to growing the finest medicinal and recreational cannabis available and helping outstanding, affordable brands like Almora and Sunsmoke reach consumers. Where we live and grow in California, we celebrate the sun and the soil and we’re able to bring out the best in every strain we passionately cultivate. We grow and harvest in accordance with the natural ebb and flow of the seasons and we produce a wide variety of extensively tested, graded, and fully compliant products. Through our organic growing practices, we strive to cycle resources, promote ecological balance, and conserve biodiversity. We believe in giving back because we truly care about this planet and its inhabitants. To learn more about us, visit www.PROFarms.Farm or contact us at info@PRO-Farms.Farm.

ABOUT ALMORA
The fastest-growing flower brand in California since 2021, Almora is farm-direct sun-grown cannabis grown in the coastal region of California. Family-owned and operated, Almora currently offers flower, concentrates, vapes, pre-rolls, infused pre-rolls and cannabis beverages. For more information, visit https://almorafarm.com.

Press Inquiries:
info@PROFarms.Farm
Sweetleafjoe@gmail.com
Greg.Bloxham@DeibelBioscience.com

End

Poll: 91% of Adults Who Have Used Cannabis Did So for Health and Wellness Purposes

6/10/2022

by

A Harris Poll survey released Wednesday found that 91% of adults 21-and-older who have ever used cannabis have done so for health and wellness purposes. The poll was conducted on behalf of Curaleaf Holdings, Inc.

The poll found that 75% of respondents would prefer holistic health solutions over pharmaceuticals with 62% saying they would prefer to use cannabis rather than pharmaceutical drugs for a medical issue.

More than half (52%) of survey respondents said they preferred to use cannabis to relax, 49% to help with sleep, 44% to reduce stress, and 41% to reduce anxiety.     

In a press release, Dr. Stacia Woodcock, clinical cannabis pharmacist for Curaleaf New York, noted that “There are a wide variety of ways to consume cannabis safely, and many formulations actually have minimal intoxicating effects.”

“Educating consumers on how cannabis can be leveraged to support everyday health and wellness needs is critical to destigmatizing the plant and providing consumers with more choices to best fit their personal lifestyle. … Different product options with various ratios of THC and CBD give patients the opportunity to consume cannabis in a way that works with their lifestyle and comfort level.” — Woodcock in a statement

The survey also found that 88% of individuals who have consumed cannabis as an alternative and/or in addition to pharmaceutical treatments feel that doing so improved their overall well-being and 86% of those who have consumed cannabis for health or wellness would recommend cannabis to a friend or family member for medical purposes.

The survey included nearly 2,000 adults in the U.S.

End

Missouri Medical Cannabis Licensees Forced to Destroy Products & Relinquish Licenses

6/10/2022

by

A group of medical cannabis cultivators in Missouri must destroy their products and relinquish their licenses as part of an agreement to resolve a dispute with the state, the St. Louis Post-Dispatch reports. Archimedes Medical Holdings, FUJM, and Holistic Health Capital signed the agreement last month following accusations of “pervasive irregularities” that prevented officials from determining whether any product from the licensees’ three grow facilities had been properly tested to “numerous outages” on security cameras that went unreported to regulators. 

The state also accused the growers of allowing employees to use and apply pesticides without training or proper equipment and leaving products unsecured. 

The agreement said the licensees “disagree with” the Department of Health and Senior Services (DHSS) position and the settlement “shall not be construed as an admission of liability or wrongdoing by any Party.” 

In an email to the Post-Dispatch, Tanner Rolfes, attorney for the licensees, said his clients “are pleased with the settlement agreement and looking forward to the future.”

“Most importantly,” he wrote, “the settlement confirms that Archimedes et al, as well as any affiliated entities or individuals, were not involved in any unlawful conduct.”

Lisa Cox, spokeswoman for the DHSS, said the primary licensees are ineligible for future licenses.

Under the agreement, licensees must transfer operational duties of the facilities to a third-party management company by the end of the month. By the end of November, the licenses must be fully transferred or they will be automatically surrendered by December 1.   

End

White House Interns Still Required to Disclose Prior Cannabis Use

6/09/2022

by

Intern applicants at the White House must continue to disclose any prior drug use — including cannabis, and even if that use occurred within a legalized state or jurisdiction — Marijuana Moment reports.

Ignoring calls to relax its drug use disclosure policies, the White House listed the requirement in an intern FAQ on its website. Candidates who advance in the hiring process will have to fill out a Security Clearance Form and past cannabis use is listed as an activity that “could affect eligibility,” the report says.

The revelation on the FAQ is not a departure from the White House’s previous stance on the issue. Reports emerged early in the Biden administration of staffers being terminated due to past cannabis use. Former Press Secretary Jen Psaki tried to dampen the controversy by stating that no staffers had been fired for “marijuana usage from years ago,” or “due to casual or infrequent use during the prior 12 months.” However, she failed to clarify whether any employees had been suspended or handed remote work after admitting to past cannabis consumption on a federal background check.

President Joe Biden (D) has long been opposed to cannabis legalization but earlier this year did grant clemency to a number of people convicted of federal cannabis crimes. It was the president’s only visible effort to follow through on his cannabis campaign trail promises, so far.

A report from last year by the Congressional Research Service (CRS) revealed that the president has the power to go further and grant mass federal pardons for cannabis convictions.

Voters in Washington DC opted to legalize adult-use cannabis in 2014 although cannabis remains strictly prohibited on federal properties.

End

Vessel Luxury Ash Trays Review

6/09/2022

by

Vessel creates both vaporizers and accessories for cannabis consumers who value design and function. Recently, Vessel sent two luxury ashtrays to Ganjapreneur: the Ash and Ember models. Ash is a 3-piece concrete ashtray with a walnut lid and walnut wood storage tray concealed under the main concrete piece. Ember is a striking and petite pure brass ashtray in a bright gold sheen with a cork footpad to protect surfaces. Both pieces feel intentionally built to incorporate into a home’s interior design without making guests feel like they’re at a college hangout.

Ember

This piece is the more compact of the two, it fits in the palm of your hand but has some weight to it. Ember was precision designed in California, both the brass and concrete versions are just one piece. Cork embellishments on the bottom ensure the nicely weighted ashtray won’t scratch surfaces. This has been a great addition to my living room. I don’t often smoke joints in that space now that we have a baby, but if there are guests over and the time is right it is very convenient to have Ember tucked into a drawer by the couch for quick sesh. I have the brass option with a gold finish but Ember also comes in concrete.

Ash

Heavy-duty but sleek, this ashtray is set up at my bedside because that is the cannabis-friendly place in my house where I most often partake. The compartments nestle under the concrete ashtray which is then covered by a walnut lid, perfect for holding my lighter and hemp wick. The compartments are designed to hold other Vessel accessories that are sold separately. Ash would blend in on a side table or coffee table and be indistinguishable from other decors. The lid allows you to place a vase or coasters on top to disguise it even further if that’s desired. The large tray and storage make it a great option for someone who uses cannabis daily, and the design makes it a great choice for the social stoner. Ash has something for everyone.

When I first set out to review luxury home decor built for the cannabis consumer I was concerned there wouldn’t be much to say. But this wasn’t an issue given Vessel Brand’s ashtrays’ intentional, precision design. Getting familiar with each piece was straightforward but also novel in its own way. The Ash is specifically novel and differentiates from other ashtrays on the market in that it conveniently stores accouterments.

These products are a level up for those cannabis consumers who are growing into their adult interior design preferences and are looking for an upscale, functional ashtray that meets their needs. Both products are designed for specific uses, and I found each to serve its purpose while also looking brilliant in my midcentury-modern home.

Find these products and more from Vessel at vesselbrand.com.

End

CO2Meter Launches New, Wall-Mounted Dual Sensor Indoor CO2 Grow Controller

6/09/2022

by

CO2Meter Inc., a worldwide leader in gas detection, monitoring, and analytical devices, released its new RAD-0502 – dual-sensor CO2 controller for grow rooms that can monitor and control carbon dioxide (CO2) concentrations at two locations from 0 to 3,000ppm. The highly anticipated dual-sensor CO2 grow controller will now provide both indoor growers and mushroom farmers the ability to control consistent CO2 levels throughout their grow space all from a central display panel.

“Our original RAD-0501 Controller is considered the gold standard for home growers and mushroom farmers. When we studied the market, we clearly saw a gap between our original RAD-0501 and the larger commercial controllers in the market. The RAD-0502 now provides indoor growers around the globe with a simple and affordable way to understand and adjust CO2 levels to optimize their growing processes.”, noted Melyssia Santiago, CO2Meter’s VP of Sales.

“Now our customers in two agricultural segments will get the added benefits of the CO2 control: growers can now control a single larger space or two different room simultaneously, and mushroom farmers now have a quality device to control ventilation.” added Santiago.

While monitoring up to two grow room locations is a significant benefit for indoor agriculture monitoring, it is not the only new feature that can be found in the RAD-0502. Customers will be able to control and monitor not only CO2 levels, but also control light, temperature, and humidity, for a full-scale optimized grow room approach. In turn, achieving unprecedented quality and yields.

Additionally, each sensor triggers individual relays allowing the end-user to control each sensor’s precise location in the facility. Whether you are looking to control grow room lighting, HVAC systems, exhaust fans, CO2 generators, or CO2 cylinders the RAD-0502 can control and monitor multiple locations at any given time. The RAD-0502 settings are user configurable, enabling the customer to apply their preferred settings for their application. And, for those looking to use the device globally, it also features a universal power supply allowing our international customers ease of use without having to use adapters.

RAD-0502 CO2 Controller for Grow Rooms

With cutting-edge, NDIR CO2 sensor technology, growers will also be reassured of the accuracy and repeatability of the sensing capabilities that can measure accurately between 0-3,000 ppm. By allowing growers the ability to apply their custom ppm settings they can optimize their indoor grow space. With an additional built-in temperature measurement and a photo sensor, users can also turn off relays during dark periods which can save them money and provide more accurate growing control.

Further RAD-0502 features include:

⦁ NDIR CO2 sensor technology
⦁ Easy-to-use, simple, and clean installation
⦁ Ability to monitor (2) zones or grow spaces
⦁ Fully customizable CO2 levels
⦁ LED identification lights
⦁ Automatic control of CO2 generators or compressed CO2 tanks
⦁ Built-in photo sensor to turn off relays in darkness
⦁ User configurable modes for both grow room or mushroom applications
⦁ Universal power supply
⦁ Enclosure resists dust, rust, and moisture

For more information on the RAD-0502, please email us at Sales@CO2Meter.com.

About CO2Meter
CO2Meter, is an industry leader in the design and manufacturing of gas detection and monitoring solutions. Our mission is to provide best-in-class CO2 monitoring and analysis solutions, while ensuring the safety, education, and long-term business of our partners worldwide. CO2Meter works diligently to utilize the latest, proven gas sensing technologies to solve the urgent needs of our customers. By providing unique, high-quality, gas detection devices we strive each day and in each customer interaction to provide education about the importance of carbon dioxide and to ensure the health, welfare, and safety of the public.

Visit CO2Meter.com and connect with us on: Facebook, Twitter, Instagram.

 

End

Delaware Lawmakers Fail to Override Governor’s Cannabis Legalization Veto

6/09/2022

by

Delaware lawmakers have failed to override Gov. John Carney’s (D) veto of a bill to legalize possession of cannabis by adults, the Associated Press reports. The override failed with a 20-20 vote, with House Majority Leader Valerie Longhurst (D) not voting. 

The measure had passed the House last month 26-14 and the Senate 13-7 on a party-line vote. A separate bill to create a taxed and regulated cannabis industry in the state failed by two votes in the House following the passage of the adult-use and possession reforms.  

Lawmakers needed a three-fifths majority to override the Democratic governor’s veto. 

Rep. Ed Osienski (D), the prime sponsor of both bills, called on his colleagues to override Carney’s veto and not wait until the governor’s second term ends in 2025 to pass the reforms.  

“…We need to fix this problem instead of just denying the freedom and the liberty of Delawareans to be able to purchase this product.” — Osienski, during his remarks on the House floor, via WHYY 

Following the vote, Carney spokeswoman Emily David said the governor “thanks the House for today’s vote and respects the role of the General Assembly and all of its members in this process.

“He looks forward to working with them on the important issues that remain this session,” she told WHYY. 

Zoë Patchell of the Delaware Cannabis Advocacy Network told WHYY that the group is “extremely disappointed in House Democratic leadership, as well as the House Democrats who changed their vote from yes to no, as well as the Republicans who changed their vote as well.” 

“Basically they could have ended cannabis prohibition by the end of this week, but they decided to not have the courage,” she said. “As a result of their actions today, there’ll be thousands of more people with a simple cannabis possession, including intrusive stops that could escalate.” 

End